A recently published study explores the possible benefits to discontinuing an alpha-1 blocker after receiving combination therapy with a 5-alpha reductase inhibitor for the treatment of benign prostatic hyperplasia (BPH). In more symptomatic patients, or patients with confirmed, enlarged prostates, it is recommended to use both medication classes (alpha-1 blocker and 5-alpha reductase inhibitor) to minimize symptoms by relaxing the prostatic smooth muscle and reducing the size of the prostate – producing a potentially synergistic effect. This study found that withdrawal of alpha 1-blockers after a year of combination therapy did not worsen urinary symptoms, QOL, and voiding or storage function. This provides evidence that combination therapy may not be needed indefinitely for all patients.
Guest Authors: Erica Crannage, PharmD and Stephanie Crist, PharmD
Music by Good Talk
Eosinophils Take the Wheel in Steering Steroid Therapy for COPD Exacerbations
SDOH Matters Too! Patient and Care Team Perspectives on Screening for SDOH
Treating Depression and Anxiety: Dosing, Pharmacogenetics, and Our Learners
Complex Patient Case 4: Diabetes, CKD, and Psoriasis
Can Losing Weight Using Semaglutide Prevent a Heart Attack, Ack, Ack, Ack, Ack?
Prescription for Savings: The Clinical and Economic Impact of Pharmacist-Led Hypertension Management in the U.S.
Heartburn Headache: Cumulative PPI Use and Dementia Risk
Does Size Matter? The Surprising Impact of Cuff Size on Blood Pressure Readings
Defining the Role of Semaglutide in Obese Patients with Heart Failure with Preserved Ejection Fraction
Do Statins “REPRIEVE” People Living with HIV from CV Events?
Top Ten Things Every Clinician Should Know About the RSV Vaccines
Complex Patient Case 3: Treatment Resistant Hypertension
Should We Be Good SPORTs About Supplements for Cholesterol?
Is Telehealth the Hidden (Hyper)Link to Controlling Blood Pressure?
Personalized Pharmacotherapy for Hypertension: Examining Intra-patient Variability
Over-the-Counter Hearing Aids – Where Do They Fit?
Road to Recovery: Pharmacist-Delivered Comprehensive Medication Management in an SUD Clinic
Gender Affirming Care - Finding the Resources You Need
Water Wars: Dueling Diuretics - Chlorthalidone vs. Hydrochlorothiazide for Cardiovascular Event Reduction
Beyond Statins: Approaches to Lipid Lowering in 2023
Create your
podcast in
minutes
It is Free
The Relaxback UK Show
Good Nurse Bad Nurse
On Call With Dr. Anselm Anyoha
The Doctor’s Farmacy with Mark Hyman, M.D.
The Peter Attia Drive